Skip to main content
SpringerLink
Log in

Although diagnosis may be challenging, bullous systemic lupus erythematosus can be effectively managed with the limited therapies available

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Bullous systemic lupus erythematosus is a relatively rare complication of systemic lupus erythematosus (SLE) that can be difficult to distinguish from other immunobullous diseases. Diagnosis requires consideration of clinical, histological and immunological factors and a concomitant SLE diagnosis. Once correctly diagnosed, dapsone, corticosteroids and/or immunosuppressants are the first treatment options to consider. If symptoms remain, rituximab may be beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517–24.

    Article  PubMed  Google Scholar 

  2. Gual A, Guilabert A, Iranzo P, et al. IgG autoantibody subclass analysis as a tool to differentiate epidermolysis bullosa acquisita with overlapping features of bullous systemic lupus erythematosus. J Am Acad Dermatol. 2013;69(1):e34–6.

    Article  PubMed  Google Scholar 

  3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

    Article  CAS  PubMed  Google Scholar 

  4. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Camisa C. Vesiculobullous systemic lupus erythematosus: a report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93–100.

    Article  CAS  PubMed  Google Scholar 

  6. Barbosa WS, Rodarte CM, Guerra JG, et al. Bullous systemic lupus erythematosus: differential diagnosis with dermatitis herpetiformis. An Bras Dermatol. 2011;86(4 Suppl 1):S92–5.

    Article  PubMed  Google Scholar 

  7. Tincopa M, Puttgen KB, Sule S, et al. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl. Pediatr Dermatol. 2010;27(4):373–6.

    Article  PubMed  Google Scholar 

  8. Pilcher MF, Metzinger AR, Davis LS. Generalized bullous eruption in a teenager. Pediatr Dermatol. 2010;27(2):197–8.

    Article  PubMed  Google Scholar 

  9. Hall RP, Lawley TJ, Smith HR, et al. Bullous eruption of systemic lupus erythematosus: dramatic response to dapsone therapy. Ann Intern Med. 1982;97(2):165–70.

    Article  CAS  PubMed  Google Scholar 

  10. Kim JH, Kim SC. Epidermolysis bullosa acquisita. J Eur Acad Dermatol Venereol. 2013;27(10):1204–13.

    CAS  PubMed  Google Scholar 

  11. Piette EW, Werth VP. Dapsone in the management of autoimmune bullous diseases. Dermatol Clin. 2011;29(4):561–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Malcangi G, Brandozzi G, Giangiacomi M, et al. Bullous SLE: response to methotrexate and relationship with disease activity. Lupus. 2003;12(1):63–6.

    Article  CAS  PubMed  Google Scholar 

  13. Fernandez-Sanchez M, Charli-Joseph Y, Saeb-Lima M, et al. Are corticosteroids and immunosuppressors an efficacious treatment for bullous lupus erythematosus with systemic manifestations? Eur J Dermatol. 2010;20(6):823–5.

    PubMed  Google Scholar 

  14. Camisa C, Sharma HM. Vesiculobullous systemic lupus erythematosus: report of two cases and a review of the literature. J Am Acad Dermatol. 1983;9(6):924–33.

    Article  CAS  PubMed  Google Scholar 

  15. Ozdemir G, Koyun M, Baysal YE, et al. Drug-induced IgA bullous dermatosis: a rare presentation of SLE. Clin Exp Rheumatol. 2010;28(4):589.

    CAS  PubMed  Google Scholar 

  16. Mekouar F, Hammi S, Elomri N, et al. Bullous systemic lupus erythematosus. Intern Med. 2011;50(13):1445.

    Article  PubMed  Google Scholar 

  17. Hamminga EA, Vermeer MH. Bullous systemic lupus erythematosus responding to mycophenolate mofetil. Eur J Dermatol. 2010;20(6):844–5.

    PubMed  Google Scholar 

  18. Pizem J, Vizjak A, Tomsic M, et al. Widespread vesiculobullous eruption in a 16-year-old male. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(3):19–22.

    CAS  PubMed  Google Scholar 

  19. Anyanwu CO, Ang CC, Werth VP. Oral mucosal involvement in bullous lupus. Arthritis Rheum. 2013;65(10):2622.

    PubMed Central  PubMed  Google Scholar 

  20. Alsanafi S, Kovarik C, Mermelstein AL, et al. Rituximab in the treatment of bullous systemic lupus erythematosus. J Clin Rheumatol. 2011;17(3):142–4.

    Article  PubMed  Google Scholar 

Download references

Disclosure

This article was adapted from the American Journal Clinical Dermatology 2014; 15(6):517–24 [1] by salaried employees of Adis/Springer and was not supported by any external funding.

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Although diagnosis may be challenging, bullous systemic lupus erythematosus can be effectively managed with the limited therapies available. Drugs Ther Perspect 31, 122–125 (2015). https://doi.org/10.1007/s40267-015-0194-0

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-015-0194-0

    Search

    Navigation